Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05995496 · ClinicalTrials.gov registry record · NA

Changes in Inhibition and Valuation After Eating

A NA study of Bulimia Nervosa, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05995496 is a NA study of Bulimia Nervosa that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 150 participants, below the 1,732-participant average among 23 other Bulimia Nervosa trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05995496, a NA study of Bulimia Nervosa, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

An impaired ability to exert control has been implicated in bulimia nervosa (BN), but this impairment may not represent a stable trait or be the most effective focus for treatment. This project aims to understand how predictions and value-based decisions about control may be abnormally influenced by eating in individuals with BN, thereby maintaining cycles of binge eating, purging, and restriction.

Conditions Studied

Bulimia Nervosa

Interventions

  • OTHER Fasting state
  • OTHER Fed state
  • OTHER Magnetic Resonance Imaging

Study Locations (1)

New York

  • Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-12-12
Est. Completion 2027-12-31
Phase NA

Sponsor

Icahn School of Medicine at Mount Sinai

708 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05995496

The ClinicalTrials.gov registry entry for NCT05995496 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,732-participant average among 23 other Bulimia Nervosa trials with a reported enrollment target (91% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bulimia Nervosa appearing as the primary indexed condition, and to 3 interventions - of which Fasting state is the first listed.

NCT05995496 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05995496 about?

NCT05995496 is a clinical study titled "Changes in Inhibition and Valuation After Eating". An impaired ability to exert control has been implicated in bulimia nervosa (BN), but this impairment may not represent a stable trait or be the most effective focus for treatment. This project aims to understand how predictions and value-based decisions about control may be abnormally influenced by...

What is the current status of trial NCT05995496?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-12-12. Estimated completion is 2027-12-31.

What conditions does trial NCT05995496 study?

This clinical trial studies the following conditions: Bulimia Nervosa.

What interventions are being tested in trial NCT05995496?

The interventions under investigation include: Fasting state (OTHER), Fed state (OTHER), Magnetic Resonance Imaging (OTHER).

Who is sponsoring clinical trial NCT05995496?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05995496 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bulimia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Bulimia Nervosa

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.